FTH Faeth Therapeutics, Inc.
Nasdaq · SEC CIK 1829802 · EDGAR
- Bought, last 12 months
- $2.53M 7 purchases by 3 insiders
- Sold, last 12 months
- $2.28M 9 sales by 3 insiders
- Filings on record
- 151 since 2021-08-02, latest 2026-09-15 16:58
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| STEPHENSON BRIAN C | CFO | $1.13M | — |
| Peyer James | 10%, See remarks below | — | $787.8K |
| Cambrian BioPharma Inc | 10% | — | $787.8K |
| Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| Hahn Stephen M. | Dir | — | — |
Transactions 121
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-13 | 2022-01-11+ | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.20 | +20.0K | 4.95M | +0.4% | +$104.2K |
| MI | 2022-01-13 | 2022-01-11+ | FTH | Peyer James | Dir, 10% | P - Purchase | $5.20 | +20.0K | 4.94M | +0.4% | +$104.2K |
| I | 2022-01-11 | 2022-01-10 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.28 | +10.0K | 4.93M | +0.2% | +$52.8K |
| 2022-01-11 | 2022-01-10 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.28 | +10.0K | 4.93M | +0.2% | +$52.8K | |
| I | 2022-01-03 | 2021-12-30 | FTH | Peyer James | Dir, 10% | P - Purchase | $4.85 | +1,127 | 4.92M | +0.0% | +$5,466 |
| 2022-01-03 | 2021-12-30 | FTH | 10% | P - Purchase | $4.85 | +1,127 | 4.92M | +0.0% | +$5,466 | ||
| I | 2021-12-30 | 2021-12-29 | FTH | Peyer James | Dir, 10% | P - Purchase | $4.98 | +69.0K | 4.92M | +1% | +$343.6K |
| 2021-12-30 | 2021-12-29 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $4.98 | +69.0K | 4.92M | +1% | +$343.6K | |
| 2021-12-29 | 2021-12-28 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.28 | +11.3K | 4.85M | +0.2% | +$59.6K | |
| I | 2021-12-29 | 2021-12-28 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.28 | +11.3K | 4.85M | +0.2% | +$59.6K |
| I | 2021-12-27 | 2021-12-27 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.30 | +3,712 | 4.84M | +0.1% | +$19.7K |
| 2021-12-27 | 2021-12-27 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.30 | +3,712 | 4.84M | +0.1% | +$19.7K | |
| 2021-12-23 | 2021-12-23 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.27 | +11.0K | 4.83M | +0.2% | +$58.0K | |
| I | 2021-12-23 | 2021-12-23 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.27 | +11.0K | 4.83M | +0.2% | +$58.0K |
| 2021-12-21 | 2021-12-17 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.29 | +117 | 4.82M | +0.0% | +$618.93 | |
| I | 2021-12-21 | 2021-12-17 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.29 | +117 | 4.82M | +0.0% | +$618.93 |
| I | 2021-12-20 | 2021-12-16 | FTH | Peyer James | Dir, 10% | P - Purchase | $5.25 | +10.9K | 4.82M | +0.2% | +$57.4K |
| 2021-12-20 | 2021-12-16 | FTH | Cambrian BioPharma Inc | 10% | P - Purchase | $5.25 | +10.9K | 4.82M | +0.2% | +$57.4K | |
| MI | 2021-12-13 | 2021-12-09+ | FTH | RICKS THOMAS G | Dir | P - Purchase | $6.24 | +40.0K | 321.8K | +14% | +$249.6K |
| I | 2021-08-12 | 2021-08-11 | FTH | Pierce Robert Hamilton | CSO | S - Sale | $7.34 | -16.0K | 0 | -100% | -$117.7K |
| MI | 2021-08-10 | 2021-08-06+ | FTH | Pierce Robert Hamilton | CSO | S - Sale | $7.12 | -79.8K | 82.4K | -49% | -$568.3K |
Purchase Sale Sale after option exercise All abbreviations